The FDA has approved a new antiplatelet agent to reduce the risk of heart attack and stroke in patients have previously had a peripheral arterial disease.
The FDA investigated the use of aspirin as a preventive method for heart attack and stroke in response to a petition to change the drug's prescribing information.
The FDA investigated the use of aspirin as a preventive method for heart attack and stroke in response to a petition to change the drug's prescribing information.
The FDA investigated the use of aspirin as a preventive method for heart attack and stroke in response to a petition to change the drug's prescribing information.
The FDA investigated the use of aspirin as a preventive method for heart attack and stroke in response to a petition to change the drug's prescribing information.
